Waters Parkerson & Co., LLC Immutep LTD Transaction History

Waters Parkerson & Co., LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2018 Nov 13, 2018	SELL	$2.45 - $3.7 $49,000 - $74,000	-20,000 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$1.32 - $2.72 $26,400 - $54,400	20,000	20,000 $31,000

2.38M

526K

222K

Ticker IMMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,000
Market Cap $180M
Description
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...

Get notified when there are updates to the investment portfolio of Waters Parkerson & Co., LLC, based on Form 13F filings with the SEC.

Stay updated on Waters Parkerson & Co., LLC with notifications on news.